EMD-76107
GluA2-STZ pre-active state with partial agonist kainic acid (KA) at 25 degrees C (consensus)
EMD-76107
Single-particle4.72 Å
Deposition: 15/03/2026Map released: 23/09/2026
Last modified: 23/09/2026
Sample Organism:
Rattus norvegicus
Sample: GluA2-STZ pre-active state with partial agonist kainic acid (KA) at 25 degrees C (consensus)
Deposition Authors: Newton TP
,
Yen LY ,
Gangwar SP ,
Sobolevsky AI
Sample: GluA2-STZ pre-active state with partial agonist kainic acid (KA) at 25 degrees C (consensus)
Deposition Authors: Newton TP
,
Yen LY ,
Gangwar SP ,
Sobolevsky AI
Pre-activation and gating pathway of AMPA receptors revealed by full and partial agonists.
Newton TP ,
Aktolun M,
Yelshanskaya MV,
Alekseev AA,
Yen LY ,
Gangwar SP ,
Sobolevsky IA,
Kurnikova MG,
Sobolevsky AI
(2026) Nat Struct Mol Biol
,
Aktolun M,
Yelshanskaya MV,
Alekseev AA,
Yen LY ,
Gangwar SP ,
Sobolevsky IA,
Kurnikova MG,
Sobolevsky AI
(2026) Nat Struct Mol Biol
Grant Support:
- National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS): F31NS147755 (United States)
- National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS): NS139087 (United States)
- National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS): F31NS132554 (United States)
- National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS): NS083660 (United States)
- National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS): NS107253 (United States)
- National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS): AR078814 (United States)
- National Institutes of Health/National Cancer Institute (NIH/NCI): CA206573 (United States)